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Analysis of genes required for host infection will pro-
vide clues to the drivers of evolutionary fitness of
pathogens like Vibrio cholerae, a mounting threat
to global heath. We used transposon insertion site
sequencing (Tn-seq) to comprehensively assess the
contribution of nearly all V. cholerae genes toward
growth in the infant rabbit intestine. Four hundred
genes were identified as critical to V. cholerae in vivo
fitness. These includedmost known colonization fac-
tors and several new genes affecting the bacterium’s
metabolic properties, resistance to bile, and ability
to synthesize cyclic AMP-GMP. Notably, a mutant
carrying an insertion in tsiV3, encoding immunity
to a bacteriocidal type VI secretion system (T6SS)
effector VgrG3, exhibited a colonization defect. The
reduced in vivo fitness of tsiV3 mutants depends on
their cocolonization with bacterial cells carrying
an intact T6SS locus and VgrG3 gene, suggesting
that the V. cholerae T6SS is functional and medi-
ates antagonistic interbacterial interactions during
infection.
INTRODUCTION
Recent regional outbreaks of cholera that have inflicted massive
morbidity andmortality in Haiti (Chin et al., 2011; Katz et al., 2013)
and in several parts of Africa (Bhattacharya et al., 2009; Mutreja
et al., 2011) underscore the continued threat of V. cholerae to
human health. Understanding which genes are required by
V. cholerae strains to infect the host will provide invaluable clues
about properties that drive the evolutionary fitness of this organ-
ism as a mounting global threat to world heath and suggest ave-
nues for development of novel therapeutics.
Studies in experimental animals (Chiang and Mekalanos,
1998;Merrell et al., 2002; Ritchie et al., 2010; Ritchie andWaldor,
2009; Taylor et al., 1987) and human volunteers (Herrington et al.,
1988; Lombardo et al., 2007) have identified many in vivo
expressed V. cholerae virulence determinants, including produc-
tion of a potent enterotoxin (CTX) (De et al., 1951) and an intes-652 Cell Host & Microbe 14, 652–663, December 11, 2013 ª2013 Elstinal colonization factor, toxin coregulated pilus (TCP) (Taylor
et al., 1987), as well as other factors coordinately regulated
with CTX and TCP (Peterson and Mekalanos, 1988). The tran-
scription of the genes encoding these two virulence factors is
controlled by the ToxT regulatory protein and a ToxT-activated
small RNA called TarB (Bradley et al., 2011; Davies et al.,
2012). RNA-seq analysis of the in vivo transcriptome of
V. cholerae suggests that the emergence of the 7th pandemic
clade of V. cholerae is genetically linked to changes in ToxT-
regulated gene expression that includes up- and downregulation
of genes located on the accessory chromosomal insertion,
termed the Vibrio 7th pandemic island I (VSP1) (Davies et al.,
2012; Mandlik et al., 2011). Specifically, the in vivo induced
TarB sRNA downregulates expression of a repressor (VspR), re-
sulting in elevation in expression of a VSP1-encoded gene, dncV
(Davies et al., 2012). DncV is an enzyme that produces the sec-
ond messenger molecule cyclic AMP-GMP (c-AMP-GMP) that
controls several phenotypes, including chemotaxis (Davies
et al., 2012), which may alter both infectivity and intestinal colo-
nization (Butler et al., 2006). A related cyclic dinucleotide has
recently been recognized as a modulator of host innate immune
responses, indicating that another layer of complexity will chal-
lenge future studies of the V. cholerae-host interaction (Danil-
chanka and Mekalanos, 2013).
The bacterial type VI secretion system (T6SS) corresponds to
a dynamic, intracellular contractile organelle (Basler and Meka-
lanos, 2012; Basler et al., 2012; Dong et al., 2013) that is evolu-
tionarily related to bacteriophage tails (Leiman et al., 2009; Pell
et al., 2009; Pukatzki et al., 2007; Shneider et al., 2013). The
V. cholerae T6SS can translocate toxic effectors into both
eukaryotic (Ma et al., 2009; Pukatzki et al., 2006, 2007) as well
as prokaryotic (Dong et al., 2013; MacIntyre et al., 2010) target
cells. In Pseudomonas species, proteins associated with T6SS
have been recognized as immunity factors in protecting
cells from the toxic effects of this anticellular system (Hood
et al., 2010; MacIntyre et al., 2010; Russell et al., 2011). In
V. cholerae these proteins clearly protect sister cells from
random T6SS attacks (Brooks et al., 2013; Dong et al., 2013).
Remarkably, little is known about the role of T6SS immunity
proteins in infected hosts despite the fact that several T6SS sys-
tems have been shown to be active in vivo by virtue of their abil-
ity to induce host damage in experimental animals (Kapitein and
Mogk, 2013; Ma and Mekalanos, 2010; Miyata et al., 2013;
Zheng et al., 2010; Ho et al., 2014).evier Inc.
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Tn-Seq Revealed T6SS Killing In Vivo ActivationRecently, we used transposon insertion site sequencing
(often referred to as Tn-seq) to establish the importance of
T6SS immunity genes to the in vitro survival of a V. cholerae
strain that constitutively expresses T6SS-dependent antibacte-
rial effectors (Dong et al., 2013). Here, we used this powerful
approach to assess the contribution of nearly 3,000
V. cholerae genes to survival and growth in the infant rabbit
intestine. We identified 400 genes in the genome of the 7th
pandemic V. cholerae strain C6706 that play significant roles
in the colonization of the infant rabbit intestine, including most
known virulence genes. Surprisingly, tsiV3 (also called tsaB),
which encodes a protein that confers immunity to the T6SS
effector VgrG3 (Brooks et al., 2013; Dong et al., 2013), was
among the group of genes required for in vivo fitness. Collec-
tively, our data suggest that V. cholerae’s T6SS mediates
antagonistic sister cell-sister cell interactions during intestinal
colonization and establish that T6SS-dependent antibacterial
activity can occur during infection of a host.
RESULTS
The ‘‘Bottleneck’’ to Infection in the Infant Rabbit Model
of Cholera Is Large Enough for a Tn-Seq-Based Study
As shown by the schematic representation of our experimental
approach in Figure 1A, we anticipated that mutants defective
in colonization as well as hypercolonizing mutants would change
in their relative abundance when passed through an animal that
could accommodate a relatively large, diverse population of
mutants. Therefore, we used the infant rabbit model of cholera,
which recapitulates many of the features of human cholera
(Ritchie et al., 2010), to perform our Tn-seq-based analysis of
the V. cholerae genes that contribute to the pathogen’s survival
and growth in the infant rabbit intestine (i.e., in vivo fitness). Since
a highly restrictive infection ‘‘bottleneck’’ would severely limit the
size of the mutant pools that could be used as the inocula for
these experiments, we initially estimated the bottleneck size in
the infant rabbit.
We first determined the minimum number of wild-type (WT)
C6706 cells required to give a consistent level of colonization
in a group of infant rabbits was a dose of 106 cells (Figure S1A).
We then inoculated rabbit pups with a 1:1 mixture of LacZ+ WT
and LacZ derivatives of C6706 WT. Eighteen hours after
different doses (inputs) of this mixture were inoculated into
pups, we determined the competitive index (CI) of these strains
in cecal contents (Figure S1B). The CI (defined as the ratio of
input LacZ/LacZ+ to output LacZ/LacZ+) was predicted to
be 1.0 for these two isogenic strains; a bottleneck would lead
to random loss of either LacZ or LacZ+ cells, and deviations
from a CI of 1.0 would be observed. A skew in the CI was
observed with the lowest inoculum level (105) but was not de-
tected when inocula of 106 or 107 bacteria were used. This anal-
ysis suggested that a maximum of 1,000 different mutants could
be analyzed together per animal, with 106 cfu per mutant
(yielding 109 total cfu in the inoculum) to avoid random loss of
mutants imposed by the bottleneck. Because we intended to
analyze a nonredundant defined library of 3,096 different
C6706 mutants (Cameron et al., 2008), we utilized seven pools
of mutants, each consisting of 480 mutants or less, as input
inocula for our animal studies.Cell Host &Transposon Insertion Sequencing, Mapping, andQuality
Control
We utilized a variant of the method described by Zhang et al.
(Zhang et al., 2012) to determine the site of TnFGL3 insertions
in the defined C6706 transposon insertion mutant library, which
includes mutants in virtually all nonessential genes that encode
open reading frames greater than 500 base pairs in length
(Cameron et al., 2008). In brief, we used short adapters, which
allowed us to sequence the chromosomal regions immediately
adjacent to TnFGL3 insertions (Figure 1B). This nested PCR pro-
cedure, which we refer to as STAT-Tn-seq (sequence-tagged
adapter-terminated Tn-seq), yielded deep sequencing reads
that map to genes known to be inactivated in the mutant sub-
pools. Critically, the number of mapped reads derived from
such pools of mutants reflects the relative abundance of any
particular mutant in the subpool.
In total, 57 STAT-Tn-seq libraries were prepared and
sequenced, corresponding to multiple technical replicates of
input pools as well as biological replicates of output pools
from at least four animals for each challenge inoculum pool.
There was an excellent correspondence between technical rep-
licates (R2 = 0.922 for the two input STAT-Tn-seq libraries) as
well as biological replicates (R2 = 0.876 for the two output
STAT-Tn-seq libraries) (Figures 1C and 1D). Collectively,
47%–89% (73% on average) of the reads matched to the ex-
pected templates (i.e., transposon mutants known to be present
in the corresponding subpools). Given the depth of Illumina
sequencing, this level of mapped reads corresponds to an
average of 10,000 mapped reads per transposon insertion
mutant in each of the input pools. These observations indicate
that STAT-Tn-seq is a reliable and reproducible method to
enrich and sequence target fragments that correspond to the
chromosomal junctions of the TnFGL3 insertions in the C6706
genome.
Identification of Genes Required for Distal Gut
Colonization
We selected STAT-Tn-seq read sets from 21 input inocula
libraries and 30 infection output libraries that displayed strong
quality parameters such as a high percent of mapped reads,
large total number of mapped reads, and balance of mapped
reads to the majority of clones within a given subpool. The reads
from these libraries were normalized between technical dupli-
cates and grouped for reads that mapped upstream and down-
stream of the same transposon insertion. The average number of
normalized input and output reads was determined for each
mutant (Figure 2B), and these values were used to calculate an
input/output ratio. This ratio corresponds to the normalized
fold change in recovery of each mutant in the output population
harvested from the cecal fluid of a given animal compared to the
input population for that animal (Figure 2A). An example of this
analysis is shown for one input pool in Table S1.
In total, 2,951 mutants were scored in this analysis (the other
145 mutants could not be assessed because they failed to be
recovered). Statistical analyses (see Experimental Procedures)
revealed that 230 mutants (7.8% of the total scored) showed a
statistically significant (p < 0.0001) reduction in their recovery
from the rabbit intestine compared to their recovery from the
inoculum. These 230 mutants displayed a 15-fold or greaterMicrobe 14, 652–663, December 11, 2013 ª2013 Elsevier Inc. 653
Figure 1. Preparation and Characterization of Infant Rabbit STAT-Tn-Seq Library
(A) Schematic depicting changes in mutant abundance during colonization of a pool of mutants in the infant rabbit host. Mutants that exhibit no defect in intestinal
replication and survival are depicted in black, colonization defective mutants (CD) in red, reduced colonization mutants (RC) in green, and mutants displaying
hypercolonization in gray. After orogastric inoculation of infant rabbits, the population of each mutant changes according to its in vivo fitness difference; these
changes in abundance can be deduced by STAT-Tn-seq analysis of the inoculum input pool and rabbit-derived output pool.
(B) Library building protocol. Genomic DNA pool was sheared by sonication, and frayed ends were repaired and modified by A tailing. An adaptor composed of
short 30 blocked (YM1.0) and long (YM2.0) oligonucleotides was ligated onto the repaired genomic DNA. The 30 end of the short adaptor oligo (YM1.0) was
blocked (*) so that it could not be extended during amplification. PCR amplification of the transposon junction site in the interrupted gene was performed using
primers that recognize the end of the transposon (YM3.0) and the 50 end of the long adaptor oligo (YM4.0). These primers contain all requisite sequences to permit
direct multiplex sequencing of amplicons on an Illumina HighSeq instrument and the sequencing primer Tn-FY-seq (YM5.0).
(C) STAT-Tn-seq analysis of input library. As a quality control step, two STAT-Tn-seq libraries were prepared from the same input subpool. Each point represents
the number of mapped reads of one mutant in each of these two technical replicates of the input pool libraries. The correlation coefficient R2 on log-transformed
abundance values is shown.
(D) STAT-Tn-seq analysis of two output libraries. Two STAT-Tn-seq libraries were prepared from bacterial cells recovered from two rabbit pups that had been
infected with the same input subpool. Each point represents the number of mapped reads of one mutant in each of the two biological replicates in the output
libraries. The correlation coefficient R2 on log-transformed abundance values is shown. Figure 1 is related to Table S1.
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Tn-Seq Revealed T6SS Killing In Vivo Activationdefect in recovery after 20 hr in the rabbit small intestine. Another
170 mutants (5.8%) displayed a 5- to 15-fold reduction in recov-
ery in vivo that also reached statistical significance (p < 0.001). A
total of 2,496 mutants (84.6%) did not change dramatically in
their abundance in the output population compared to their input
abundance, showing less than a 5-fold reduction in recovery.
Interestingly, 55 mutants (1.9%) showed a 5-fold or greater
growth advantage in vivo that was also statistically significant654 Cell Host & Microbe 14, 652–663, December 11, 2013 ª2013 Els(see below) (Figures 2C and 2D). All the normalized sequencing
data used to categorize mutants into these various groups are
listed in Table S2. For simplicity, we decided to call all mutants
showing a statistically significant, 15-fold or greater reduction
in their recovery as ‘‘colonization defective’’ or CD mutants
(Table S4i). Mutants showing between 5- and 15-fold defects
in colonization were designated ‘‘reduced colonization’’ or RC
mutants (Table S4ii).evier Inc.
Figure 2. STAT-Tn-Seq Data Analysis
(A) Example data for three mutants showing normal, reduced colonization (RC), or colonization defective (CD) phenotypes. The number of STAT-Tn-seqmapped
reads to genes VC1403, VC1545, and VC0239 are shown for three technical replicates of the input inoculum library (Input R1-R3) and four output libraries (Out R1-
R4) derived from four separate infected rabbits. Normalized reads are shown. The t test was used to compare normalized reads to derive p values for the dif-
ferences between the average number of mapped reads for the input (In AVG) versus the output (Out AVG) libraries as well as the calculated input/output fold
change in the ratio of the mapped reads (Fold I/O).
(B) Normalized total mapped read count of 2,951 defined Tnmutants. Each spot represents themapped reads in the input and output populations for an identified
TnFGL3mutant. CDmutants are shown in red, RCmutants in green, hypercolonizingmutants in gray, and all other mutants are shown in black. The location of the
dot corresponding to the mapped reads for the mutant carrying a transposon insertion in VCA0124 (tsiV3) is circled in blue, and in VCA0177 (vspR) is circled in
black.
(C) Distribution of the number of mutants displaying different output/input ratios. Each bar reflects the total number of the different transposon mutants that
displayed various output/input ratios in the particular interval on the scale. The cut-off for CD mutants is 0.067 (1/15), RC mutants 0.2 (1/5), and IP mutants 0.5.
(D) Fold defect in intestinal colonization compared to p value determined for normalized output versus input mapped STAT-Tn-seq reads. Each point represents a
different TnFGL3 mutant. Fold change in the input/output ratio is expressed in log2 fold and the p values in log10. The location of the mutant carrying an insertion
in vspR is indicated by the red triangle, and the tsiV3 mutant is denoted by a black rhombus. Figure 2 is related to Table S2.
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Tn-Seq Revealed T6SS Killing In Vivo ActivationValidation of CD Mutants
To initially validate our list of CD genes, we examined whether
this list includes previously discovered genes that contribute to
V. cholerae survival/growth in the intestine. Forty-seven genesCell Host &have been previously documented as required for intestinal colo-
nization in the sucking mice model of cholera (reviewed by
Ritchie and Waldor, 2009); 38 of these genes were disrupted in
the 230 CD mutants (Figure 3A). Furthermore, all analyzedMicrobe 14, 652–663, December 11, 2013 ª2013 Elsevier Inc. 655
Figure 3. Verification of Colonization Defective Mutants Identified
with STAT-Tn-Seq
(A) Venn diagram of genes found to be defective in colonization of mice and
rabbits. Of 230 CD mutants found in this infant rabbit study, 38 mutants were
also present in the group of 47 genes important in the colonization of infant
mice in previous studies.
(B) Competition assays with multi-mutant subpools of CD mutants. Seven
groups of seven LacZ+ TnFGL3 mutant strains were each mixed with the wild-
typeLacZC6706parental strain in an input ratio of 1:1 for all eight strains. Each
group of eight strains was used to infect groups of infant rabbits, and after
infection the ratio of LacZ to LacZ+ was determined on indicator medium.
Each point reveals the average C.I. of the entire LacZ+ mutant pool in a given
subgroup (M1-M7) compared to the LacZWT in the corresponding subgroup.
The unusually higher competitive index in group M4 was determined to be
caused by one mutant (VC0126) that displayed only about a 3-fold defect in
colonization. Statistical significance was determined by t test comparing the
C.I. for various pairs to the C.I. determined for a competition between WT
C6706 versusC6706 lacZ::Tn, with **** indicating a p value < 0.0001.Meanwith
SEM was shown. Figure 3 is related to Figure S2 and Table S3.
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Tn-Seq Revealed T6SS Killing In Vivo Activationmutants with insertions in TCP genes showed a severe defect in
colonization except the insertion mutant VC0828/EC11096,
which has a TnFGL3 insertion in tcpA (Figures S2A and S2B).
This was a surprise given that TcpA is the major subunit of the
TCP pilus (Taylor et al., 1987). However, the TnFGL3 insertion
in this mutant lies within the 30 last 10% of the tcpA coding
sequence and thus could be producing a functional but trun-656 Cell Host & Microbe 14, 652–663, December 11, 2013 ª2013 Elscated TcpA product; an in-frame deletion in tcpA in C6706 ex-
hibited a 100-fold defect in a competition assay in infant rabbits
(Figure S2C). It is possible that other TnFGL3 insertions that do
not inactivate their respective genes have led us to slightly un-
derestimate the true number of V. cholerae CD genes; 3% of
all intragenic insertions in the nonredundant defined TnFGL3
library are found in the 30 10% of coding sequences. For
example, the TnFGL3 insertion site of both VC2206/flgP and
VC0823/mop are in the 30 10% interval. These two genes have
been reported to be important for intestinal colonization in
mice but were not shown to be defective in our Tn-seq analysis.
To confirm that our STAT-Tn-seq analysis was identifying
mutants defective in colonization in the context of our multiplex
infection protocol, we retested the in vivo fitness of a subset of
CD mutants in direct competition assays versus WT. We
selected 49 CD mutants (Table S3) and pooled these in seven
subgroups (M1-M7) containing seven mutants each that dis-
played similar defects in the initial screen. Subgroups M1–M7
were also spiked with a LacZ WT parental strain. Despite the
fact that the WT strain was introduced into each mixture as a
minority member in the total inoculum, in all cases the WT strain
outcompeted the TnFLG3 mutants (Figure 3B). Collectively,
these data illustrate the power and reliability of our STAT-Tn-
seq protocol in identifying mutants that are defective in coloniza-
tion in the infant rabbit model.
Predicted Functions of Gene Products Required for
V. cholerae Intestinal Colonization
The 230 genes inactivated in the CD mutants were subjected to
bioinformatic analyses to address their functions. Their predicted
functional categories are shown in Figure 4A. Previous study of
this TnFGL3 nonredundant library showed that, overall, nearly
43% of genes of V. cholerae have no predicted function and
21% of genes contributed to metabolic function (Cameron
et al., 2008). However, in our CD group, metabolism (41%) was
the largest functional category; also, a large percentage of the
geneproducts hadnopredicted function (21%), agroup thatwar-
rants future investigation (Figure 4A). In many cases, gene prod-
ucts classified in other functional categories can have a fairly
direct contribution to survival/growth in the host. For example,
many genes classified in the carbohydrate metabolism category
are known to be involved in lipopolysaccharide biosynthesis, an
outer membrane component known to be critical for intestinal
colonization (Chiang and Mekalanos, 1999; Nesper et al.,
2001). Over half (56%) of the CD gene products were predicted
to be cytoplasmic proteins, consistent with the large number
of genes predicted to contribute to the metabolic activity of
V. cholerae, including pathways devoted to carbohydrate meta-
bolism, energy production, and the biosynthesis of nucleotides,
vitamins, cofactors, and amino acids (Figures 4B and 4C). Gene
products predicted to be periplasmic or associatedwith the inner
or outer membrane of V. cholerae represented 27% of the 230
gene products, including components of known secretion sys-
tems such as the type II extracellular protein secretion (EPS) sys-
tem (Korotkov et al., 2012), and those driving assembly of the
extracellular, essential colonization factor, the TCP pilus (Craig
et al., 2003; Peterson and Mekalanos, 1988; Taylor et al., 1987).
Collectively, the V. cholerae CD genes identified by STAT-Tn-
seq analysis include many known pathogenicity determinants.evier Inc.
Figure 5. Colonization Assays on vspR and dncV Mutants
Left: The in vivo competitive index was determined for a phenotypically LacZ+
TnFGL3 mutant carrying an insertion in lacZ (lacZ::Tn) competed against its
parentalDlacZWTstrain (WT). The in vivo competitive indexwasdetermined for
a phenotypically LacZ+ TnFGL3 insertion in vspR (vspR::Tn) when competed
against its DlacZ parental strain (WT) at an input inoculum dose of either 109
(middle left) or 106 (middle right). Right: The in vivo competitive index was
determined for dncV::Tn competed with WT strain. Mean with SEM is shown.
Figure 4. Predicted Function and Subcellular Location of CD Gene
Products
(A) Pie chart for functional categories.
(B) Pie chart for metabolic functional categories for the 94 CD mutants that
were predicted to affect metabolic functions.
(C) Pie chart for the predicted subcellular localization for the protein products
encoded by CD mutants.
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Tn-Seq Revealed T6SS Killing In Vivo ActivationMutants Displaying Modest Colonization Defects and
Significant Hypercolonization Phenotypes
The list of 400 genes interrupted in the CD and RCmutants does
not include all of the genes that are likely to contribute to
V. cholerae survival/growth in the rabbit intestine. A total of 240
of 2,951mutants (8.1%) have less than a 5-fold reduction in colo-
nization but a highly significant p value (p < 0.001) (Figure 2D and
Table S4iii). This group (impaired colonization or IP mutants) in-
cludes mutants that have been previously identified as coloniza-
tion defective in the infant mousemodel of cholera. For example,
a mutant with an insertion in VC0179, the gene encoding theCell Host &c-AMP-GMP synthetase DncV (Davies et al., 2012), was previ-
ously reported to be partially defective in colonization in infant
mice, but this mutant was not in our CD and RC lists. The
VC0179 mutant had a 3-fold colonization defect that was
observed in all of five experimental animals infectedwith the sub-
pool containing this mutant (p value = 0.0003). We performed an
in vivo competition assay to verify this phenotype and confirmed
that the DncVmutant is reduced in colonization by approximately
4-fold (Figure 5). Remarkably, this result is consistent with other
Tn-seq data indicating that an insertion in VspR (the negative
regulator of dncV) has a hypercolonization phenotype. Indeed,
the vspRmutant had the highest andmost statistically significant
(p <0.0001) increase in intestinal colonization relative toWT in our
library and was enriched in its corresponding mutant subpool by
27-fold over other coinfected strains. Because other chemotaxis
mutantswere also scored as significantly elevated in colonization
relative to WT (Table 1), we tentatively conclude that inactivation
of VspR likely caused the in vivo overexpression of DncV. Over-
expression of DncV is known to induce a nonchemotactic pheno-
type in vitro (Davies et al., 2012), andnonchemotactic cells (Butler
et al., 2006) and mutants (Butler and Camilli, 2004) have been re-
ported to hypercolonize the infant mice intestine. To confirm the
rabbit hypercolonizationphenotype,weperformedacompetition
assay between the vspR::TnFGL3 mutant and WT in infant rab-
bits. As shown in Figure 5, the vspR mutant outcompeted the
WT strain, especially in animals infected with a low challenge
inoculum of 106 cfu. Thus, our STAT-Tn-seq analysis provides in-
dependent evidence supporting the hypothesis that the in vivoMicrobe 14, 652–663, December 11, 2013 ª2013 Elsevier Inc. 657
Table1. Chemotaxis Function-Related Genes whose Inactivation Causes Hyper Colonization in Infant Rabbits
Gene ID Gene Name Fold Enrichment (by STAT-Tn-seq) Functional Annotation/Known Function
VC0177 vspR 27.05 Repressor of dncV
VC1859 methyl-accepting
chemotaxis protein
24.40 Cellular processes; cell motility; bacterial chemotaxis
VC0892 pomA 11.87 Chemotaxis protein PomA
VC1399 cheR 5.26 Chemotaxis protein methyltransferase/cellular
processes; cell motility; bacterial chemotaxis
VC2063 cheA 3.80 Chemotaxis protein methyltransferase/cellular
processes; cell motility; bacterial chemotaxis
We are unable to evaluate several other che genes (cheB, cheV, cheW, and cheY) because these genes are duplicated in the V. cholerae chromosome.
Cell Host & Microbe
Tn-Seq Revealed T6SS Killing In Vivo ActivationinducedTarBsRNAcauseshypercolonizationbydownregulating
VspR and upregulating DncV (Davies et al., 2012).
Phenotypic Analysis of CD Mutants
Since our Tn-seq analysis was performed on an ordered trans-
poson library, we were able to retest mutants screened in vivo
for further characterization. In particular, we carried out several
phenotypic screens on CD mutants where the explanations for
their marked in vivo growth deficits were not obvious. Initially
we tested 192 TnFGL3 insertionmutants that had no clear expla-
nation for their CD phenotype for resistance to bile, a toxic deter-
gent-like agent present in the small intestine that can restrict
bacterial growth (Provenzano et al., 2000; Sikora et al., 2007).
Seventeen of the mutants showed sensitivity to 0.5% crude
bile when scored for growth on LB agar plates or in liquid cultures
containing 0.5% sodium cholate (Figure S3 and Table S5). Eight
exhibited severe defects (no growth on L agar containing 0.5%
crude bile), while the other nine showed an intermediate defect.
Among these candidates, tolC and Eps component genes have
been previously shown to contribute to bile resistance, and a
deletion of epsC-N was shown to cause a significant defect in
mouse intestinal colonization (Bina andMekalanos, 2001; Sikora
et al., 2007). Additionally, inactivation of VC1981, a gene pre-
dicted to encode a cysteine/glutathione ABC transporter mem-
brane/ATP-binding protein, also produced a bile sensitivity
phenotype. Because conjugation of glutathione is frequently
used to inactivate toxic small molecules in eukaryotic cells
(Tew and Townsend, 2012), our data suggest that VC1981 may
produce bile resistance through a cysteine- or glutathione-
dependent mechanism.
We also tested the same 192 CD mutants for their ability to
grow in M9 glucose minimal media under aerobic and anaerobic
conditions. The growth rate and maximal cell density for each
mutant was assessed (Table S6). We found that 45 mutants dis-
played an obvious growth defect in M9 glucose medium when
incubated aerobically (doubling time > 500 min, maximum
OD600 < 0.05 versus doubling time 100 min and maximum
OD600 = 0.15 for WT), andmost of thesemutants harbored inser-
tions in genes predicted to have metabolic or biosynthetic func-
tions (Figure S4). Because these CD mutants are auxotrophic
and clearly have a defect for growth in glucose minimal media
but not in rich medium (LB), we conclude that the infant rabbit in-
testine is likely to be comparably depleted in nutritional content.
The intestinal environment also likely presents a gradient of
oxygen to V. cholerae during the colonization process, with the658 Cell Host & Microbe 14, 652–663, December 11, 2013 ª2013 Elsmucosal surface being microaerophilic and the luminal space
being largely anaerobic (Marteyn et al., 2011). Because
V. cholerae is a facultative anaerobe, we tested whether any of
the CD mutants we identified were deficient in their ability to
replicate under anaerobic conditions. As a control, we found
that WT C6706 replicates on glucose M9 minimal medium under
anaerobic conditions robustly (doubling time 130 min and
maximum OD600 = 0.15). Surprisingly, only one CD mutant, car-
rying an insertion in carA, showed an intermediate defect in
growth only under anaerobic conditions (Figure S5). These
data suggest that fermentativemetabolism is not critically impor-
tant to V. cholerae when colonizing the infant rabbit and further
suggest that aerobic, not anaerobic, metabolism is more likely
the source of energy for this bacterium during intestinal
colonization.
Unexpected Phenotypes Associated with Colonization
Defective Mutants
Included on the list of CDmutants identified by our STAT-Tn-seq
analysis were twomutants that had insertions within genes asso-
ciated with the V. cholerae T6SS (VCA0122 and VCA0124/tsiV3).
This was surprising because this gene cluster was previously
shown to be poorly expressed by C6706 and nonfunctional in
bacterial killing assays performed on laboratory media (Zheng
et al., 2010). The first of the two mutants carried a TnFGL3 inser-
tion in VCA0122, a gene previously found to not be essential for
T6SS function but that is located 50 to the gene (VCA0123) en-
coding a major antibacterial, lysozyme-like effector, VgrG3
(Brooks et al., 2013; Dong et al., 2013). The second mutant
identified carried a TnFGL3 insertion in the gene immediately
downstream of vgrG3, VCA0124, which encodes TsiV3/TsaB, a
protein that confers immunity to VgrG3 (Brooks et al., 2013;
Dong et al., 2013). Because the insertion in VCA0122 might be
polar on VCA0123 and VCA0124 expression in vivo, we elected
to focus our attention on the latter two genes and the following
hypothesis: T6SS-mediated killing of the VCA0124::TnFGL3
mutant in vivo occurs within mucosal biofilms as a result of sister
cell T6SS-dependent attacks with the VgrG3 effector. Remark-
ably, there have been no reports of T6SS-dependent antibacte-
rial activity within an infected animal host (Ho et al., 2014).
In order to test this hypothesis, we made a series of single and
double in-frame deletion mutations in various genes and per-
formed competition assays in rabbits to test whether the coloni-
zation defect of a VC0124 mutant required the function of the
T6SS organelle. As shown in Figure 6A, the tsiV3::TnFGL3evier Inc.
Figure 6. Immunity to and Induction of the
T6SS of C6706 Contributes to Intestinal
Colonization in the Infant Rabbit Model
(A and B) In vivo competition experiments were
performed comparing the indicated tsiV3 related
mutants (A) and tsiV2 relatedmutants (B) to parental
strain C6706. Statistical significance was deter-
mined by t test relative to the C.I. determined for
a competition between WT C6706 versus C6706
lacZ::TnFGL3,with **** indicatingapvalue<0.0001.
(C) Bacterial killing of T6SS immunity mutant
defective in TsiV3 under in vitro culture conditions.
The tsiV3::TnFGL3mutantwas used as a prey strain
for killing by V. cholerae predator strains V52 (ex-
presses functional T6SS killing activity in vitro), V52
DvasK (defective in T6SS killing), V52 DvgrG3 (has
functional T6SS but does not secrete the effector
protein of TsiV3), and C6706 WT (inactive in T6SS
killingunder invitrogrowthconditions). Thepredator
strainswere individuallymixedwith the tsiV3mutant
on L agar at 37C for 3 hr prior to determine the
viable counts of the TsiV3 mutant on L agar con-
tainingkanamycin.Only theV52predator noticeably
kills the TsiV3 under these in vitro conditions.
(D) Transcript level determination for T6SS genes
of C6706 WT when grown in vitro in LB versus
in vivo in the infant rabbit host. Transcript level
was determined by quantitative RT-PCR and is
expressed as fold enrichment of transcripts in vivo
compared to in vitro relative to 16S rRNA. Tran-
scripts for two housekeeping genes (gyrB and
rpoB) that are not directly involved in T6SS func-
tion are shown as controls. Three rabbit biological
replicates were sampled for each gene. Signifi-
cance was determined by t test: **p < 0.01, ***p <
0.001, ****p < 0.0001. Mean with SEM is shown.
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competed against WT C6706, showing a 100-fold defect in in-
testinal colonization. A mutant harboring an in-frame deletion of
tsiV3 was also highly defective in colonization in competition
versus WT but not when competed with a vipA (YFJM2) mutant
that is defective in T6SS function. These data suggest that the
competing WT strain killed the tsiV3 mutant in vivo in a T6SS-
dependent manner. We suspected that even the residual
2-fold reduction in colonization of the tsiV3 mutant relative to
the competing vipA mutant was explainable by the fact that
tsiV3 mutant cells were sensitive to killing by their T6SS+ sister
cells. This prediction was confirmed by the observation that a
vipA tsiV3 double mutant and a vipA single mutant exhibited
equal in vivo fitness in an in vivo competition experiment (Fig-
ure 6A). Thus, a functional T6SS organelle is necessary to pro-
duce the observed changes in the in vivo fitness of the tsiV3
mutant in these competition assays.
To further explore this interesting in vivo phenotype, a
vgrG3::TnFGL3 insertion mutant was competed with the DtsiV3
mutant in infant rabbits. We found that the tsiV3 mutant
competed better versus the vgrG3 mutant than versus WT (Fig-
ure 6A), consistent with the concept that this cognate antibacte-
rial effector is required for the colonization defect ofDtsiV3when
competed against the WT strain. In contrast, a vipA DtsiV3 dou-
ble mutant showed only a slight defect in colonization relative to
the vgrG3::TnFGL3 mutant, indicating that if both strains lackCell Host &VgrG3 killing function, then loss of TsiV3 has no deleterious
effect on intestinal colonization. Together, these data strongly
suggest that tsiV3mutants are defective in colonization primarily
because they are sensitive to killing by the VgrG3 effector deliv-
ered by either cocolonizing T6SS+ strains or their own sister
cells.
Curiously, our STAT-Tn-seq analysis did not reveal a coloniza-
tion defect associated with loss of TsiV2, the immunity protein to
the T6SS antibacterial effector VasX (Dong et al., 2013). To
confirm this, an in-frame deletion of tsiV2 was made, and when
this mutant was competed with WT, it displayed no defect in in-
testinal colonization (Figure 6B). A mutant defective in another
V. cholerae T6SS immunity protein, TsiV1 (Dong et al., 2013),
was not represented in our transposon mutant library. However,
our results with TsiV3 and VgrG3 suggest that expression of at
least one cognate immunity and antibacterial effector is function-
ally expressed by 7th pandemic strain C6706 in vivo during infec-
tion of infant rabbits.
To provide further evidence that the observed phenotype
might reflect differences in the expression or functionality of
the T6SS and the VgrG3 effector in vivo compared to in vitro,
we performed killing assays on C6706 WT and C6706 DtsiV3
mutant on agar media (Figure 6C). These data indicated that
the DtsiV3mutant was indeed sensitive to killing by V52 (consti-
tutively expresses a functional T6SS in vitro) but not to V52 vasK
(inactive in T6SS function). Consistent with previous findingsMicrobe 14, 652–663, December 11, 2013 ª2013 Elsevier Inc. 659
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indicating this strain does not express a functional T6SS
in vitro. Collectively, these data indicate that the T6SS is func-
tionally expressed in vivo by C6706, a conclusion that is sup-
ported by a recent RNA-seq-based transcriptome analysis of
the genes expressed by V. cholerae C6706 during infection in
suckling mice (Mandlik et al., 2011) and gene fusion reporters
in human volunteers (Lombardo et al., 2007).
To confirm that the T6SS of C6706 was upregulated in infant
rabbits, we used quantitative real-time PCR to measure the level
of mRNA transcripts corresponding to T6SS genes present in
bacteria harvested from the upper intestinal mucosa. This anal-
ysis showed that of the eight T6SS genes analyzed, five were
significantly in vivo induced compared to in vitro grown cells,
including the T6SS effector gene vgrG3 and immunity gene
tsiV3, which were 5-fold and 12-fold upregulated (Figure 6D).
Transcripts corresponding to the genes encoding the effector
TseL and its cognate immunity protein TsiV1 were 4-fold and
14-fold enriched, respectively, suggesting that this effector/
immunity gene pair is also elevated in expression in vivo. Collec-
tively, these data support the hypothesis that for 7th pandemic
strain C6706, the transcription of T6SS is elevated in vivo and
that increased expression of two particular effectors (VgrG3,
TseL) contributes to the antibacterial activity of this strain during
infection.
DISCUSSION
For over three decades, transposon insertion mutagenesis has
provided numerous insights into critical features of pathogens.
The recent application of ‘‘deep sequencing’’ to the challenge
of tracking the relative abundance of various transposon inser-
tion mutants in multiplex analyses has provided an exciting
high-throughput negative selection approach to comprehen-
sively identify genes required for selectable phenotypes (Chao
et al., 2013; Dong et al., 2013; Gallagher et al., 2011; van Opijnen
andCamilli, 2013;Wong et al., 2013; Zhang et al., 2012). Ordered
transposon insertion libraries also can facilitate comprehensive
analysis of pathogen-host interactions as well as provide inves-
tigators with an opportunity to ‘‘cherry pick’’ mutants for further
analysis. In this study, we have combined these two approaches
by utilizing an ordered transposon insertion library (Cameron
et al., 2008) as the template for our Tn-seq analysis to determine
which genes are required for V. cholerae intestinal colonization.
Furthermore, this nonredundant set of TnFGL3 mutants allowed
us tominimize the absolute number ofmutants that needed to be
analyzed per infected animal aswell as the number of animals we
needed to use to carry out our nearly comprehensive analysis of
the contribution of V. cholerae ORFs to intestinal colonization.
We scored the in vivo fitness of nearly 3,000 mutants using our
STAT-Tn-seq analysis. In total, we found that 400 (12%) of the
mutants we screened exhibited dramatic reductions in their
in vivo fitness. Several lines of evidence strongly support the
accuracy of this list. First, we found that in competitions with
WT, CD mutants showed similar colonization defects that were
estimated from STAT-Tn-seq analyses of the larger mutant
pools. Second, the gene clusters involved in TCP and LPS pro-
duction as well as the type II generalized protein secretion sys-
tem were prominently represented in our list; mutations that660 Cell Host & Microbe 14, 652–663, December 11, 2013 ª2013 Elsinterrupt all three of these clusters are known to cause marked
colonization defects (Chiang and Mekalanos, 1998; Korotkov
et al., 2012; Merrell et al., 2002; Peterson and Mekalanos,
1988; Ritchie and Waldor, 2009; Taylor et al., 1987). Similarly,
38 of 47 previously identified loci that contribute to colonization
of the suckling mouse intestine (Ritchie and Waldor, 2009) were
identified within the CD group of mutants in our study. Of the 9
mutants that missed this cross-species determined cutoff, 3
each were in the RC and IP groups, and the other 3 have TnFGL3
insertions that probably do not inactivate their respective genes.
Thus, we conclude that the great majority of the 400 genes iden-
tified here (Table S4, sheet 1 and sheet 2) contribute to the in vivo
fitness of V. cholerae in the infant rabbit intestine and probably
other mammalian gastrointestinal tracts as well. This list of 400
genes will be a valuable resource for future investigations; in
particular, deciphering how many of the 80 genes of unknown
function on this list contribute to V. cholerae survival/growth in
the host intestine constitutes a key challenge for future studies.
Among the most surprising categories of genes found to be
essential for colonization, there were two that are located in
the V. cholerae T6SS gene cluster. Previous studies have re-
vealed that there is little expression of the C6706 T6SS locus
in vitro and that regulatory mutations are required to elevate its
transcription and reveal its functionality in vitro (Zheng et al.,
2010). Here, we found that inactivation of genes encoding the
C6706 T6SS organelle per se was not associated with the CD
phenotype, suggesting that this secretion system is not required
for in vivo fitness as a result of its activity directed at the host.
Instead, we found that mutants in VCA0124, a gene encoding
an immunity protein TsiV3/TsaB that blocks the antibacterial
T6SS effector VgrG3, exhibit marked (>50-fold) colonization de-
fects. The CD defect of tsiV3mutants was largely suppressed by
inactivation of the gene encoding VipA, an essential T6SS sheath
component (Basler et al., 2012; Kapitein and Mogk, 2013; Lei-
man et al., 2009) (Figure 6A). Because VCA0124 encodes immu-
nity to the antibacterial T6SS effector VgrG3 (Brooks et al., 2013;
Dong et al., 2013), we hypothesized that the CDphenotype of the
tsiV3mutant reflected its sensitivity to the VgrG3 effector in vivo.
This idea was validated by competition assays that showed that
the CD phenotype of the TsiV3 mutant was also suppressed by
inactivation of VgrG3. Finally, RT-PCR analyses confirmed that
expression of vgrG3 and tsiV3, as well as tseL and tsiV1, were
elevated in bacteria recovered from the rabbit distal small intes-
tine. Together, these data suggest that themarked attenuation of
the growth/survival of the tsiV3 mutant in vivo results from its
susceptibility to VgrG3-mediated attack. Either T6SS+ VgrG3+
TsiV3 sister cells or other T6SS+ VgrG3+ TsiV3+ coinfected
strains could mediate killing in these competition experiments.
In either case, our observations strongly support the conclusions
that (1) during colonization of the infant rabbit mucosal surfaces,
V. cholerae forms biofilm-like structures where close bacterial
cell-cell contact can occur, (2) V. cholerae T6SS expression is
elevated in the intestine relative to in vitro growth conditions,
and (3) the in vivo expressed T6SS is active in killing sensitive
bacterial cells during the infection process. While previous ob-
servations buttress all three of these conclusions, our findings
provide important insights into V. cholerae intestinal colonization
and the role of T6SS in this process. Scanning electron micro-
scope images have previously revealed that V. cholerae formsevier Inc.
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lial surface (Nelson et al., 1976; Ritchie et al., 2010), and indeed
the major intestinal colonization factor TCP mediates a strong
cell-cell autoagglutination phenotype in vitro and in vivo (Jude
and Taylor, 2011; Taylor et al., 1987). Our work now demon-
strates that there can be profound functional consequences
(cell death) to the cell-cell contacts that form on mucosal sur-
faces. Furthermore, the expressions of many T6SS systems
have been shown to be regulated by signals involved in biofilm
formation or signals present in the host (Kapitein and Mogk,
2013; Miyata et al., 2013). To our knowledge, there has been
no report that demonstrates antibacterial activity of a T6SS
in vivo during infection of a host animal. Because host mucosal
surfaces frequently carry diverse populations of commensal
microorganisms, our data suggest the intriguing possibility that
T6SS antibacterial activity might also influence the indigenous
microbiota of the host in ways that enhance the colonization of
pathogenic T6SS+ species. T6SS antibacterial activity may be
particularly important to pathogens that enter into consortia
(i.e., mixed biofilms) with commensal organismswhere the indig-
enous species exhibit antagonistic or competitive behaviors to
the superinfecting pathogen.
The demonstration that immunity to antibacterial T6SS
effector function is necessary for host colonization is an observa-
tion that is unprecedented in the T6SS field. This finding sug-
gests that bacterial cells are in sufficient proximity to each other
in vivo to render them susceptible to T6SS-mediated attack by
their own sister cells. We propose that T6SS immunity proteins
may often be critical to in vivo fitness, particularly for T6SS+
organisms that form biofilms on host mucosal surfaces. These
would include organisms such as P. aeruginosa (Hood et al.,
2010; Mougous et al., 2006; Russell et al., 2011) and other
enteric and mucosal Gram-negative bacterial pathogens that
form biofilms in vivo. Thus, small molecules that inhibit the func-
tion of T6SS effector immunity proteins might be promising lead
compounds for highly species-specific, anti-infective drugs
against such Gram-negative organisms. Enlisting the endoge-
nous T6SS antibacterial armamentarium of target pathogens
presents a previously untested approach for development of
antimicrobial agents.
EXPERIMENTAL PROCEDURES
Ethics Statement
All animal experiments were performed with protocols approved by the Har-
vard Medical School Office for Research Protection Standing Committee on
Animals in accordance to NIH guidelines. See also Supplemental Information.
Bacterial Strains and Growth Conditions
All the strains used in this study are listed in Table S7A. C6706, a 1991 Peruvian
El Tor O1 clinical isolate, was the WT V. cholerae strain used in this study.
E. coli DH5a lpir and Sm10 lpir were used as host strains for cloning and
conjugation, respectively. Antibiotic concentrations were used at the following
concentrations: streptomycin (Sm: 200 mg/ml), kanamycin (Kan: 50 mg/ml),
carbenicillin (Carb: 75 mg/ml), and chloramphenicol (Cm: 2.5 mg/ml for
V. cholerae and 10 mg/ml for E. coli strains). X-gal (40 mg/ml) was used for
Blue/White screen.
Transposon Mutant Library Preparation
Mutants were grown individually in 200 ml LB Sm and Kan per well in 96-well
plates (Costar) overnight at 37C with a final OD600 close to 1.0. Then, the cul-Cell Host &tures corresponding to 480 mutants per subpool were mixed in equal volume
with the final concentration at 109 cfu/ml. One ml of subpool mixtures were
used as input challenge inocula per animal and for preparation of input
STAT-Tn-seq libraries. After sacrificing the rabbits, cecal fluid samples were
immediately collected and used to prepare output Tn-seq libraries. Bacteria
cells were recovered by centrifugation and DNA was extracted immediately
without an in vitro growth step. All primers and adaptor DNA oligos used are
listed in Table S7B.
Infant Rabbit Colonization Competition Assays
V. cholerae strains were initially grown overnight on LB-agar plates at 37C. A
fresh colony of each strain was inoculated in LB and incubated at 250 rpm at
37C for about 6 hr. Cultures were adjusted to OD600 = 1.0. WT and mutant
strains weremixed together in 2.5% sodium bicarbonate buffer and inoculated
into 2-day-old New Zealand white rabbit pups (109 bacteria/animal). After
typically 18 hr, or when symptoms were apparent, pups were sacrificed and
dissected, and a 1 cm distal small intestine sample was removed and homog-
enized in 1 ml of PBS. Serial dilutions were plated in LB with Sm and X-gal to
enumerate the output ratio of the WT and mutant strain. The competitive index
for each mutant is defined as the input ratio of mutant/WT strain divided by the
output ratio of mutant/WT strain. A minimum of six rabbits were assayed for
each mutant strain.
Multicompetition assays were used to confirm the STAT-Tn-seq results for
49 selected mutants. The protocol used was virtually the same as the compe-
tition assays for single mutants except that seven transposon mutants were
present in each experimental group along with a LacZ WT strain. The input
ratio of each single mutant:WT in these multicompetition assays was approx-
imately 1:1, so the cumulative mutant:WT ratio was approximately 7:1.
SUPPLEMENTAL INFORMATION
Supplemental Information includes five figures, Supplemental Experimental
Procedures, and seven tables and can be found with this article online at
http://dx.doi.org/10.1016/j.chom.2013.11.001.
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